79 related articles for article (PubMed ID: 29254787)
1. Downregulation of miR-10B* is correlated with altered expression of mitotic kinases in osteosarcoma.
Roberto GM; Engel EE; Scrideli CA; Tone LG; Brassesco MS
Pathol Res Pract; 2018 Feb; 214(2):213-216. PubMed ID: 29254787
[TBL] [Abstract][Full Text] [Related]
2. p53-Dependent and cell specific epigenetic regulation of the polo-like kinases under oxidative stress.
Ward A; Hudson JW
PLoS One; 2014; 9(1):e87918. PubMed ID: 24498222
[TBL] [Abstract][Full Text] [Related]
3. DNA Methylation Mediated Downregulation of miR-449c Controls Osteosarcoma Cell Cycle Progression by Directly Targeting Oncogene c-Myc.
Li Q; Li H; Zhao X; Wang B; Zhang L; Zhang C; Zhang F
Int J Biol Sci; 2017; 13(8):1038-1050. PubMed ID: 28924385
[TBL] [Abstract][Full Text] [Related]
4. PLK1-associated microRNAs are correlated with pediatric medulloblastoma prognosis.
Pezuk JA; Brassesco MS; de Oliveira RS; Machado HR; Neder L; Scrideli CA; Tone LG
Childs Nerv Syst; 2017 Apr; 33(4):609-615. PubMed ID: 28283778
[TBL] [Abstract][Full Text] [Related]
5. Demethylation of miR-10b plays a suppressive role in ccRCC cells.
He C; Zhao X; Jiang H; Zhong Z; Xu R
Int J Clin Exp Pathol; 2015; 8(9):10595-604. PubMed ID: 26617769
[TBL] [Abstract][Full Text] [Related]
6. DNA methylation-mediated repression of miR-886-3p predicts poor outcome of human small cell lung cancer.
Cao J; Song Y; Bi N; Shen J; Liu W; Fan J; Sun G; Tong T; He J; Shi Y; Zhang X; Lu N; He Y; Zhang H; Ma K; Luo X; Lv L; Deng H; Cheng J; Zhu J; Wang L; Zhan Q
Cancer Res; 2013 Jun; 73(11):3326-35. PubMed ID: 23592755
[TBL] [Abstract][Full Text] [Related]
7. A novel interplay between HOTAIR and DNA methylation in osteosarcoma cells indicates a new therapeutic strategy.
Li X; Lu H; Fan G; He M; Sun Y; Xu K; Shi F
J Cancer Res Clin Oncol; 2017 Nov; 143(11):2189-2200. PubMed ID: 28730284
[TBL] [Abstract][Full Text] [Related]
8. The deregulated promoter methylation of the Polo-like kinases as a potential biomarker in hematological malignancies.
Ward A; Sivakumar G; Kanjeekal S; Hamm C; Labute BC; Shum D; Hudson JW
Leuk Lymphoma; 2015 Jul; 56(7):2123-33. PubMed ID: 25347426
[TBL] [Abstract][Full Text] [Related]
9. DNA methylation contributes to deregulation of 12 cancer-associated microRNAs and breast cancer progression.
Pronina IV; Loginov VI; Burdennyy AM; Fridman MV; Senchenko VN; Kazubskaya TP; Kushlinskii NE; Dmitriev AA; Braga EA
Gene; 2017 Mar; 604():1-8. PubMed ID: 27998789
[TBL] [Abstract][Full Text] [Related]
10. miR-15b modulates multidrug resistance in human osteosarcoma in vitro and in vivo.
Duan Z; Gao Y; Shen J; Choy E; Cote G; Harmon D; Bernstein K; Lozano-Calderon S; Mankin H; Hornicek FJ
Mol Oncol; 2017 Feb; 11(2):151-166. PubMed ID: 28145098
[TBL] [Abstract][Full Text] [Related]
11. Altered expression of miRNAs and methylation of their promoters are correlated in neuroblastoma.
Maugeri M; Barbagallo D; Barbagallo C; Banelli B; Di Mauro S; Purrello F; Magro G; Ragusa M; Di Pietro C; Romani M; Purrello M
Oncotarget; 2016 Dec; 7(50):83330-83341. PubMed ID: 27829219
[TBL] [Abstract][Full Text] [Related]
12. Functional elucidation of MiR-34 in osteosarcoma cells and primary tumor samples.
He C; Xiong J; Xu X; Lu W; Liu L; Xiao D; Wang D
Biochem Biophys Res Commun; 2009 Oct; 388(1):35-40. PubMed ID: 19632201
[TBL] [Abstract][Full Text] [Related]
13. The downregulation of miR-144 is associated with the growth and invasion of osteosarcoma cells through the regulation of TAGLN expression.
Zhao M; Huang J; Gui K; Xiong M; Cai G; Xu J; Wang K; Liu D; Zhang X; Yin W
Int J Mol Med; 2014 Dec; 34(6):1565-72. PubMed ID: 25318625
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-149 is epigenetically silenced tumor-suppressive microRNA, involved in cell proliferation and downregulation of AKT1 and cyclin D1 in human glioblastoma multiforme.
Ghasemi A; Fallah S; Ansari M
Biochem Cell Biol; 2016 Dec; 94(6):569-576. PubMed ID: 27783537
[TBL] [Abstract][Full Text] [Related]
15. p53-dependent activation of microRNA-34a in response to etoposide-induced DNA damage in osteosarcoma cell lines not impaired by dominant negative p53 expression.
Novello C; Pazzaglia L; Conti A; Quattrini I; Pollino S; Perego P; Picci P; Benassi MS
PLoS One; 2014; 9(12):e114757. PubMed ID: 25490093
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic silencing of miR-708 enhances NF-κB signaling in chronic lymphocytic leukemia.
Baer C; Oakes CC; Ruppert AS; Claus R; Kim-Wanner SZ; Mertens D; Zenz T; Stilgenbauer S; Byrd JC; Plass C
Int J Cancer; 2015 Sep; 137(6):1352-61. PubMed ID: 25704289
[TBL] [Abstract][Full Text] [Related]
17. MiR-26a inhibits stem cell-like phenotype and tumor growth of osteosarcoma by targeting Jagged1.
Lu J; Song G; Tang Q; Yin J; Zou C; Zhao Z; Xie X; Xu H; Huang G; Wang J; Lee DF; Khokha R; Yang H; Shen J
Oncogene; 2017 Jan; 36(2):231-241. PubMed ID: 27270422
[TBL] [Abstract][Full Text] [Related]
18. miR-217 targeting Wnt5a in osteosarcoma functions as a potential tumor suppressor.
Wei R; Deng Z; Su J
Biomed Pharmacother; 2015 May; 72():158-64. PubMed ID: 26054690
[TBL] [Abstract][Full Text] [Related]
19. miR-24 represses metastasis of human osteosarcoma cells by targeting Ack1 via AKT/MMPs pathway.
Liu Z; Liu Z; Zhang Y; Li Y; Liu B; Zhang K
Biochem Biophys Res Commun; 2017 Apr; 486(2):211-217. PubMed ID: 28189676
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of miR-132 by promoter methylation contributes to pancreatic cancer development.
Zhang S; Hao J; Xie F; Hu X; Liu C; Tong J; Zhou J; Wu J; Shao C
Carcinogenesis; 2011 Aug; 32(8):1183-9. PubMed ID: 21665894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
